The CHMP has given a positive recommendation to Dupixent for COPD while the FDA ...
The EMA’s CHMP gave a positive opinion for Abbvie’s Skyrizi as the company bolst...
Global drug supply chains could be further disrupted as foreign pharma inspector...
The Swiss pharma ecosystem is on an upward trajectory after a tough economic yea...
Midland Pharmaceuticals has launched to focus on the development of a therapeuti...
While commercial uptake may be difficult for ivonescimab, a positive regulatory ...
There is a great unmet need for treatment options that halt, reverse, or cure am...
A Phase III trial with the drug has shown improved molecular response rates comp...
Discover key factors in choosing a compound medication pharmacy and the latest a...
The EC has granted orphan medicinal product designation for Rocket Pharmaceutica...
The US FDA approved Teva Pharmaceuticals’ AUSTEDO XR as a once-daily treatment o...
Decentralized clinical trials are driving new complexities in data collection. T...
With the completed acquisition, Sanofi will gain access to SAR447537, Inhibrx’s ...
Royalty Pharma will receive 15% on US sales of vorasidenib, up to $1bn, and at a...
Several personalities, including a Nobel-winning scientist who helped discover H...
The company has fired 53% of its workforce and is shutting down the development ...
